Lactulose in cirrhosis: Current understanding of efficacy, mechanism, and practical considerations
Open Access
- 12 October 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 7 (11)
Abstract
HE is a complication of cirrhosis characterized by neuropsychiatric and motor dysfunction, and results in decreased quality of life and increased mortality. Lactulose is a synthetic disaccharide used to treat HE since 1966, though many questions about its use remain unanswered. Lactulose reverses minimal HE, prevents overt HE, improves quality of life, increases the rate of recovery from overt HE, and improves survival rates. Lactulose’s clinical effect appears to be derived from its impact on intestinal microbes, likely a result of its enteric acidifying effect, positive pressure on beneficial taxa, and improvement of gut barrier function. There are several practical considerations with lactulose including (1) a need to avoid excessive bowel movements and subsequent dehydration, (2) treatment titration protocols need further investigation, (3) baseline or treatment-induced gastrointestinal side effects limit adherence in some cases, and (4) the utility of monitoring stool consistency or pH remains unknown. Further research is needed to optimize our use of this effective treatment for HE.Keywords
This publication has 69 references indexed in Scilit:
- Enteric dysbiosis associated with a mouse model of alcoholic liver diseaseHepatology, 2010
- Predictors of the recurrence of hepatic encephalopathy in lactulose‐treated patientsAlimentary Pharmacology & Therapeutics, 2010
- Endotoxemia produces coma and brain swelling in bile duct ligated ratsHepatology, 2007
- Prospective, randomized, parallel‐group trial to evaluate the effects of lactulose and polyethylene glycol‐4000 on colonic flora in chronic idiopathic constipationAlimentary Pharmacology & Therapeutics, 2004
- Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: A double-blind, randomized clinical trialHepatology, 1987
- The Fermentation of Lactulose by Colonic BacteriaMicrobiology, 1982
- Lactulose.Gut, 1970
- TREATMENT OF CHRONIC PORTAL-SYSTEMIC ENCEPHALOPATHY WITH LACTULOSEThe Lancet, 1966
- Inability of the human small-intestinal lactase to hydrolyze lactuloseBiochimica et Biophysica Acta (BBA) - Enzymology and Biological Oxidation, 1965
- Der Bifidusfaktor1DMW - Deutsche Medizinische Wochenschrift, 1957